Home › Compare › CHGCY vs O

CHGCY vs O: Dividend Comparison 2026

CHGCY yields 2.99% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CHGCY wins by $405.79M in total portfolio value
10 years
CHGCY
CHGCY
● Live price
2.99%
Share price
$27.52
Annual div
$0.82
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$405.82M
Annual income
$381,294,826.82
Full CHGCY calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.18
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,098.20
Full O calculator →

Portfolio growth — CHGCY vs O

📍 CHGCY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCHGCYO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CHGCY + O cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CHGCY pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHGCY
Annual income on $10K today (after 15% tax)
$253.82/yr
After 10yr DRIP, annual income (after tax)
$324,100,602.80/yr
O
Annual income on $10K today (after 15% tax)
$448.90/yr
After 10yr DRIP, annual income (after tax)
$4,333.47/yr
At 15% tax rate, CHGCY beats the other by $324,096,269.33/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHGCY + O for your $10,000?

CHGCY: 50%O: 50%
100% O50/50100% CHGCY
Portfolio after 10yr
$202.93M
Annual income
$190,649,962.51/yr
Blended yield
93.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

CHGCY
No analyst data
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.6% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHGCY buys
0
O buys
0
No recent congressional trades found for CHGCY or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCHGCYO
Forward yield2.99%5.28% ✓
Annual dividend / share$0.82$3.23 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100% ✓15.1%
Portfolio after 10y$405.82M ✓$34.2K
Annual income after 10y$381,294,826.82 ✓$5,098.20
Total dividends collected$404.01M ✓$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: CHGCY vs O ($10,000, DRIP)

YearCHGCY PortfolioCHGCY Income/yrO PortfolioO Income/yrGap
1← crossover$11,297$597.22$10,818$607.86+$479.00 → CHGCY
2$13,349$1,261.10$11,786$741.30+$1.6K → CHGCY
3$17,069$2,785.33$12,944$910.50+$4.1K → CHGCY
4$24,921$6,656.96$14,343$1,127.28+$10.6K → CHGCY
5$44,832$18,166.72$16,053$1,408.17+$28.8K → CHGCY
6$109,057$61,087.10$18,167$1,776.65+$90.9K → CHGCY
7$394,447$277,755.94$20,815$2,266.60+$373.6K → CHGCY
8$2,299,836$1,877,777.60$24,179$2,927.66+$2.28M → CHGCY
9$22,925,198$20,464,373.86$28,521$3,833.95+$22.90M → CHGCY
10$405,824,789$381,294,826.82$34,218$5,098.20+$405.79M → CHGCY

CHGCY vs O: Complete Analysis 2026

CHGCY — Stock

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; renal diseases consist of Mircera and Oxarol; and neurology/other diseases comprise Hemlibra, CellCept, and Enspryng. It has various development product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, renal diseases, neurology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances with Roche Group; and collaboration and joint research with academia. The company was founded in 1925 and is headquartered in Tokyo, Japan. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd.

Full CHGCY Calculator →

O — REIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this CHGCY vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHGCY vs SCHDCHGCY vs JEPICHGCY vs KOCHGCY vs MAINCHGCY vs STAGCHGCY vs ADCCHGCY vs NNNCHGCY vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.